The document discusses translation disregulation mechanisms in various neurodegenerative and mitochondrial diseases. It describes defects in prion/tau proteins, FUS protein, and other factors that can alter translation leading to diseases like ALS, frontotemporal dementia, and mitochondrial diseases. It also discusses translation defects in inherited protein synthesis disorders and mitochondrial translation defects.
The document discusses translation disregulation mechanisms in various neurodegenerative and mitochondrial diseases. It describes defects in prion/tau proteins, FUS protein, and other factors that can alter translation leading to diseases like ALS, frontotemporal dementia, and mitochondrial diseases. It also discusses translation defects in inherited protein synthesis disorders and mitochondrial translation defects.
The document discusses translation disregulation mechanisms in various neurodegenerative and mitochondrial diseases. It describes defects in prion/tau proteins, FUS protein, and other factors that can alter translation leading to diseases like ALS, frontotemporal dementia, and mitochondrial diseases. It also discusses translation defects in inherited protein synthesis disorders and mitochondrial translation defects.
The document discusses translation disregulation mechanisms in various neurodegenerative and mitochondrial diseases. It describes defects in prion/tau proteins, FUS protein, and other factors that can alter translation leading to diseases like ALS, frontotemporal dementia, and mitochondrial diseases. It also discusses translation defects in inherited protein synthesis disorders and mitochondrial translation defects.